You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PERIDEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Peridex patents expire, and what generic alternatives are available?

Peridex is a drug marketed by 3M and is included in one NDA.

The generic ingredient in PERIDEX is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Peridex

A generic version of PERIDEX was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PERIDEX?
  • What are the global sales for PERIDEX?
  • What is Average Wholesale Price for PERIDEX?
Summary for PERIDEX
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 42
Clinical Trials: 10
Patent Applications: 6,899
What excipients (inactive ingredients) are in PERIDEX?PERIDEX excipients list
DailyMed Link:PERIDEX at DailyMed
Drug patent expirations by year for PERIDEX
Recent Clinical Trials for PERIDEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State UniversityPhase 4
Montefiore Medical CenterN/A
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterPhase 2

See all PERIDEX clinical trials

Pharmacology for PERIDEX
Physiological EffectDecreased Cell Wall Integrity

US Patents and Regulatory Information for PERIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m PERIDEX chlorhexidine gluconate SOLUTION;DENTAL 019028-001 Aug 13, 1986 AT RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.